Stunning Changes in FDA's Software Regulation (+)

  • Speaker:Casper Uldriks
  • Duration:60Min
  • Product Code:GRC-90610

Live Session - How it works

  • Username and Password will be sent to you within 24 hours prior to the webinar.
  • Presentation handouts in pdf format will be emailed to along with the login instructions or few hours before the meeting starts.
  • Login to the session by clicking on “Join the Meeting” in the login instructions and then dial the number to connect to the meeting audio or use your Computer to connect to audio. Please use the name and the email address you used at the time of registration to join the meeting.
  • Get answer to your queries through interactive Q&A sessions. The Q and A sessions are at the end of the meeting. The expert will complete his/ her presentation and then the phone lines will be open for the audience to discuss your questions.
  • Please let us know your thoughts and views at the end of webinar, your valuable feedback will help us improve our Training programs.
  • Certificate of attendance is emailed to you within 6 working days from the date the webinar was completed. If you don’t receive an email within 6 days. Please email our support@grcts.com

Recorded Session - How it works

  • Login Information with Password to view the webinar will be emailed to you within 48 hours from the date the Live webinar was completed. The link to the recording is for a single person use only and it is valid for 6 months or the actual duration the recording was purchased.
  • Please click on the link to access the Recording and type in the password provided in the email.
  • Presentation and other handouts will be emailed to you in a pdf format.

Training CD - How it works

  • Free shipment within 2 working days, from the date the webinar was completed. The presentation and other handouts will be emailed to you in a pdf format if we are unable to attach them in the CD or USB.

(For more information about our products contact +1- 248-233-2049)

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. Access the Recording of the Training for 6 months. Contact our support for any questions. To prepare an invoice to pay by Check or Wire email us at support@grcts.com. 

This webinar will highlight the changing circumstances with respect to software regulations and FDA’s approach from a regulation to voluntary standard. How to understand the qualifications and terms of participation to clear its software for marketing, what to do in case of cybersecurity intrusion and how to update regulatory program as mobile apps are removed from FDA’s regulatory oversight.

Congress removed some software products out of FDA's jurisdiction. On balance, the benefit did not outweigh the cost of the regulatory burden. That is a stunning "least burdensome approach." FDA is planning to give additional regulatory relief to its regulation of software. Now the question is whether or not you are in a "relief zone." Those boundaries are grey. We are looking at no regulation of some software, easier regulation for some software premarket (510(k)) submissions and an accelerated assessment of products deemed part of a "Digital Health" initiative, which has a startling change for premarket access. Firms can clear their own Software 510(k).

Objectives of the Presentation

  • Identify software that is no longer regulated by the FDA
  • Identify FDA guidance documents that will be revised or withdrawn
  • Identify mobile apps exempt from FDA regulation
  • Identify premarket shortcuts for software 510(k) clearance
  • Identify recall reporting options for cybersecurity problems
  • Highlight the FDA's Digital Health initiative

Why Should you Attend:
FDA's regulation of software provides major relief to firms involved with software, especially low risk software. Firms should be re-evaluated the software they market to determine if the regulatory relief applies to the software they market. Are you developing your risk assessment? Criteria so you can justify saying, (1) "My software is not regulated" (2) "Does my firm meet the criteria to clear its own software 510(k)'s?" or (3) "My software qualifies as digital health software." These are questions that require work now so that you reap the rewards going forward.

Areas Covered

  • 21st century cure act impact
  • Software no longer under FDA jurisdiction
  • Changes in premarket requirements
  • Voluntary controls short cuts
  • Post market reporting options
  • Digital Health Initiative - FDA clearance not required

Who will Benefit

  • Regulatory affairs directors
  • Software designers / specification developers
  • Production managers
  • Quality assurance directors
  • In-house legal counsel
  • Importers of software-based devices
  • Software engineers
  • information technology managers
  • Third party software services
  • Regulatory Affairs Managers
  • Healthcare institution risk managers
  • Complaint investigation teams
  • Quality assurance directors

Topic Background
FDA has struggled with regulating software for about 25 years. When the Federal Food, Drug, and Cosmetic Act (FDCA) was amended in 1976 to regulate devices, software was not considered. It did not exist as a regulatory issue. With the advent of increasingly sophisticated software, the increasing use of software and the dramatic increase of mobile apps, FDA, the industry, and Congress became aware that FDA was in over its head. Congress has redefined the scope of FDA's jurisdiction over software. In a rare case in history, FDA is scaling back its regulatory boundaries.

Instructor Profile:
Mr. Uldriks held a number of positions at FDA, such as an investigator in FDA's New England office, in the Office of the Commissioner in Legislative Affairs and in the Center for Devices and Radiological Health (CDRH), where he served as CDRH's Associate Director for Regulatory Guidance and Government Affairs. He helped to guide CDRH to develop and implement various medical device related amendments to the Food, Drug, and Cosmetic Act, regulations and guidance documents. For years he has trained FDA staff on medical law and has been a featured speaker at many professional conferences involving FDA's medical device program. 
Bar Admissions: Massachusetts, 1986 and District of Columbia, 2011
Education: Suffolk University Law School, Boston, Massachusetts, 1986.

Write a review

Please login or register to review

Available Options

Live Meeting Access Single: Attend the Live Meeting Online from any location

$169

Recording: Unlimited Viewing Access for 6 Months

$229

CD-DVD: Shipped within 2 working days

$279

USB - Shipped within 2 working days

$289

5 Member Group: 5 people can Attend the Live Online Meeting from any location globally

$589

10 Member Group: 10 people can Attend the Live Online Meeting from any location globally

$849

Related Products

Validation of Analytical Methods according to the New FDA Guidance (+)

Validation of Analytical Methods according to the New FDA Guidance (+)

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. Access the recording of the webinar for 6 months. Contact our support for any questions. To prepare an invoice to pay by Check or Wire email us at support@grcts.com.  Description: FDA has released a new comprehensive guidance for validation of analytical methods. The guidance follows the modern integrated life cycle approach with related new requirements for using quality-by-design compone..

$169

FDA Regulations Governing GCP, GLP and GMP

FDA Regulations Governing GCP, GLP and GMP

 Description:It is important for the FDA-regulated industry to better understand applicable FDA regulations governing Good Laboratory Practice (GLP), Good Clinical Practice (GCP) and current Good Manufacturing Practice (cGMP) for drugs, biologics and medical devices including in vitro diagnostics (IVDs).This webinar is intended to help the FDA-regulated industry get better familiar with the GLP, GCP and cGMP requirements from regulatory and compliance perspectives.Good understanding and ade..

$2659

Validation and Use of Cloud Computing in FDA Regulated Environments

Validation and Use of Cloud Computing in FDA Regulated Environments

Description:Cloud computing can significantly reduce investment and operating costs for IT operations. However when used in FDA and other regulated environments they need to be validated to ensure consistent on-going performance and security and integrity of stored and managed data. While there are guidelines available on how to deal with standard networks this is not the case for virtual networks and cloud computing, This seminar will give a good understanding of FDA requirements of cloud compu..

$269

Raw Materials Risk Management in GMP Facilities: Avoiding GMP non-Compliance Due to Raw Material Issues

Raw Materials Risk Management in GMP Facilities: Avoiding GMP non-Compliance Due to Raw Material Issues

Description: Many FDA observations during GMP audits include issues that pertain to raw materials. Most warning letters sent by FDA to GMP plants will cite raw material management problems. FDA auditors pay a close eye to the ways that your raw materials are sourced, controlled, handled, accounted for and utilized at each facility. Raw material management is cited in many GMP regulations for all sorts of products regulated by FDA, including pharmaceuticals, biologics, medical devices, dietary..

$209

Medical Device Design: Dos and Don'ts - Special Considerations

Medical Device Design: Dos and Don'ts - Special Considerations

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. Access the recording of the webinar for 6 months. Contact our support for any questions. To prepare an invoice to pay by Check or Wire email us at support@grcts.com. Description:Medical device manufacturers are required to establish and maintain FDA-compliant quality management systems, where appropriate and applicable, including a design control subsystem.  This presentation is intend..

$3269

Medical Device Risk Analysis in the Design Process

Medical Device Risk Analysis in the Design Process

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. Access the Recording of the Training for 6 months. Contact our support for any questions. To prepare an invoice to pay by Check or Wire email us at support@grcts.com. Certification: GRCTS Attendance CertificateBackground:Medical Devices by their very nature must be safe for human use and must meet the requirements for which they have been designed.  The process which identifies the risks ..

$2659

ICD-10-CM Official Guidelines for Coding and Reporting - FY 2019

ICD-10-CM Official Guidelines for Coding and Reporting - FY 2019

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. Access the Recording of the Training for 6 months. Contact our support for any questions. To prepare an invoice to pay by Check or Wire email us at support@grcts.com.  Description This webinar will discuss overviews of each of the four sections of 2019 ICD-10-CM Guidelines for Coding and Reporting. These are the guidelines that payers use when processing your claims. It will teach how accu..

$349

Writing and Enforcing Effective SOPs (Standard Operating Procedures)

Writing and Enforcing Effective SOPs (Standard Operating Procedures)

If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. Access the recording of the webinar for 6 months. Contact our support for any questions. To prepare an invoice to pay by Check or Wire email us at support@grcts.com. Overview Almost every paragraph of the Quality System Regulation says that manufacturers shall “establish” procedures”.  This webinar will help you to write clear, unambiguous, and flexible SOPs that accompli..

$169